Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.
Oncotarget
; 6(4): 2101-19, 2015 Feb 10.
Article
in En
| MEDLINE
| ID: mdl-25544764
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Receptors, Erythropoietin
/
Dacarbazine
/
Glioma
Language:
En
Journal:
Oncotarget
Year:
2015
Document type:
Article
Affiliation country:
France
Country of publication:
United States